Related Experiment Video
Updated: Jun 4, 2025

09:20
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.4K
Insights into Cancer Cell Imaging Probes Based on Chalcone Scaffolds: Theoretical and Experimental Perspectives
A Mumthaj1,2, M Umadevi3, Mookkandi Palsamy Kesavan2
1PG Research Department of Chemistry, Nehru Memorial College (Autonomous), , Puthanampatti, (Affiliated to Bharathidasan University), 626 002, Tiruchirappalli, Tamil Nadu, India.
Journal of Fluorescence
|December 18, 2024
Summary
Researchers developed novel chalcone-chromone scaffolds. AZBNPy demonstrated potent anticancer activity by targeting key proteins and showed promise for cancer imaging in MCF-7 cells.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Molecular Biology
Background:
- Chalcone-chromone scaffolds are recognized for their diverse biological activities.
- Developing targeted anticancer agents and imaging probes remains a critical challenge in oncology.
Purpose of the Study:
- To synthesize novel chalcone-chromone-based scaffolds using multicomponent reactions.
- To evaluate the anticancer potential and diagnostic capabilities of the synthesized compounds, particularly AZBNPy.
- To investigate the molecular mechanisms underlying AZBNPy's efficacy.
Main Methods:
- Multicomponent reactions for scaffold synthesis.
- Spectroscopic characterization (NMR, FT-IR, HR-MS) for structural elucidation.
- In vitro assays for cell proliferation inhibition and cell death induction.
- Molecular docking studies to predict binding interactions.
- In vitro fluorescence imaging for cancer cell receptor specificity.
Main Results:
- Successful synthesis and characterization of chalcone-chromone scaffolds.
- AZBNPy exhibited significant DNA and protein binding capabilities.
- Molecular docking suggested AZBNPy as a potential anticancer agent and imaging probe.
- AZBNPy effectively inhibited MCF-7 cell proliferation by targeting HER-2, PARP-2, and HFR.
- In vitro imaging confirmed AZBNPy's specific fluorescence in human breast cancer tissues.
Conclusions:
- AZBNPy is a promising anticancer agent with dual functionality for therapy and imaging.
- The compound's ability to target specific cancer biomarkers offers potential for precise diagnostics.
- AZBNPy shows clinical promise for optical imaging in cancer surgery to improve tissue identification and removal.

